EcoDrugPlus

Adenosine Receptor A1-Like

Ensembl ID : ENSGMOG00000036320
Gene Symbol: LOC115556887
2 Cross references
145 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSGMOG00000010743
Gene Symbol: LOC115546523
2 Cross references
39 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSGMOG00000030635
Gene Symbol: LOC115549661
2 Cross references
152 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSGMOG00000004760
Gene Symbol: ADRA1AA
3 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSGMOG00000031337
Gene Symbol: ADRA1B
3 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSGMOG00000020001
Gene Symbol: ADRA1D
2 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSGMOG00000025715
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSGMOG00000000928
Gene Symbol: ADRA2B
3 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSGMOG00000007906
Gene Symbol: ADRA2C
1 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSGMOG00000031749
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSGMOG00000001811
Gene Symbol: ADRB2A
3 Cross references
195 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSGMOG00000029564
Gene Symbol: ADRB3A
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).